Bernardo Cortese, MD, FESC (he/him/his)

consultant Cardiologist
Fondazione Ricerca e Innovazione Cardiovascolare
Milano, Lombardia, Italy

Bernardo Cortese, MD
Interventional Cardiologist

Current position(s):
consultant cardiologist at Galeazzi-Sant'Ambrogio Hospital Milano
consultant cardiologist at San Raffaele Hospital Milano
President, scientific committee Fondazione RIC
Director of the Fellowship program in Advanced Interventional Cardiology (ESC), Milano

previous:
-Director of Cardiology, San Carlo Clinic, Milano

Fellow of the European Society of Cardiology (FESC)
Fellow of the Indo-European Course of Revascularization (FIECR)
Member of the Scientific Committee of the Italian Society of Interventional Cardiology (GISE)

Telephone Number, Email, Website
bcortese@gmail.com www.bernardocortese.com

Presentation(s):

• The Fate of Coronary Dissections Left After Sirolimus-Coated Balloon Angioplasty | A Prespecified Sub-Analysis of the Eastbourne Study

  Saturday, February 25, 2023
  1:00 PM – 1:10 PM ET

  Disclosure information not submitted.

• BRS, DES and DCB Technologies (Non-CME)

  Sunday, February 26, 2023
  2:00 PM – 5:55 PM ET

  Disclosure information not submitted.

• Long Term Clinical Outcomes After DCB-PCI: Potential Advantages Over Current DES - A 2023 Update

  Sunday, February 26, 2023
  3:02 PM – 3:10 PM ET

  Disclosure information not submitted.

• Panel Discussion: Will DCB Play a Role for Coronary Application in the US?

  Sunday, February 26, 2023
  3:34 PM – 3:50 PM ET

  Disclosure information not submitted.

• The Evidence Behind the DCB: From the Largest DCB Study - EASTBOURNE to the TRANSFORM RCTs

  Sunday, February 26, 2023
  7:20 PM – 7:30 PM ET

  Disclosure information not submitted.

• Panel Discussion and Conclusion

  Sunday, February 26, 2023
  7:45 PM – 8:00 PM ET

  Disclosure information not submitted.

• CARDIOTUBE INTERVIEW: DCB, the Last Frontier for Coronary Revascularization?

  Monday, February 27, 2023
  2:30 PM – 2:40 PM ET

  Disclosure information not submitted.

• CARDIOTUBE INTERVIEW: The Fate of Coronary Dissections Left After Sirolimus-coated Balloon Angioplasty. A Prespecified Sub-Analysis of The Eastbourne Study.

  Monday, February 27, 2023
  4:00 PM – 4:10 PM ET

  Disclosure information not submitted.